Sign in

CIK 0001652130 · Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364785571
Phone
857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. 144 Insider Sale of Securities
  5. ARS Other Annual Report to Security Holders
  6. DEFA14A Proxy Proxy Materials
  7. S-8 Other Securities Offered to Employees in Benefit Plans
  8. 144 Insider Sale of Securities
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. ARS Other Annual Report to Security Holders
  11. DEFA14A Proxy Proxy Materials
  12. S-8 Other Securities Offered to Employees in Benefit Plans
  13. S-8 Other Securities Offered to Employees in Benefit Plans
  14. ARS Other Annual Report to Security Holders
  15. DEFA14A Proxy Proxy Materials
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. 144 Insider Sale of Securities
  18. 144 Insider Sale of Securities
  19. S-3ASR Offering Registration Statement
  20. 144 Insider Sale of Securities

Page 1 of 3 · 58 filings